Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |